U.S. Senator Tammy Baldwin Applauds Obama Administration Action to Help Reduce Wisconsin’s Rape Kit Backlog
Wisconsin’s Department of Justice to Receive $2 Million Federal Investment After Baldwin Calls on U.S. Attorney General to Take “Immediate Steps” to Address Backlog
WASHINGTON, D.C. – U.S. Senator Baldwin released the following statement after Vice President Joe Biden and U.S. Attorney General Loretta E. Lynch today announced $41 million in grant awards to 20 jurisdictions to eliminate or reduce the number of untested sexual assault kits across the country, including $2 million for the Wisconsin Department of Justice. Yesterday, Senator Baldwin sent a letter to U.S. Attorney General Lynch calling for the Department of Justice to take “immediate steps” after a recent USA Today investigation revealed at least 70,000 sexual assault kits remain untested nationwide, including more than 6,000 in Wisconsin.
“Today’s announcement from the Department of Justice is a major step toward helping victims of sexual assault in Wisconsin and across the country access the swift and thorough justice they deserve,” said Senator Baldwin. “The current backlog in Wisconsin and across the country leaves victims and their families without closure and potentially puts other members of our communities at risk of sexual violence, but I am hopeful this federal investment will provide local law enforcement with resources and technical assistance that can help them eliminate the backlog as quickly as possible.”
As a member of the Senate Appropriations Committee, Senator Baldwin supported the Fiscal Year 2016 Commerce, Justice, Science and Related Agencies Appropriations Act, which included strong funding for the Debbie Smith Act and directed the Department of Justice to use the vast majority of this funding specifically to reduce the backlog in testing sexual assault kits. In 2004, Congress passed the Debbie Smith Act authorizing federal grants to assist local law enforcement in the testing of backlogged DNA samples, and has twice reauthorized this law with overwhelming, bipartisan support.
Today’s announcement is part of an unprecedented partnership with the New York County District Attorney’s Office (DANY) – whose own grant program is contributing $38 million to the cause for a total of $79 million to eliminate the backlog reaching 43 jurisdictions in 27 states across the country.
Press Releases by Tammy Baldwin
U.S. Senator Tammy Baldwin Announces $1.5 Million to Expand Apprenticeship Opportunities Across WisconsinOct 21st, 2016 by Tammy Baldwin
“Apprenticeship initiatives are one of the most effective vehicles for responding to the workforce readiness needs of business and industry,” said Senator Baldwin.
U.S. Senator Tammy Baldwin Calls on Wisconsin Attorney General Brad Schimel to Get the Job Done on Wisconsin’s Longstanding Rape Kit BacklogOct 5th, 2016 by Tammy Baldwin
More than one year after Wisconsin Justice Department received federal investments, reports show state still has 6,000 kit backlog
U.S. Senator Tammy Baldwin Statement on Investigations into Madison and Milwaukee Social Security OfficesSep 21st, 2016 by Tammy Baldwin
For the past year, Baldwin has worked on behalf of whistleblowers and raised questions about wrongdoing, harassment and retaliation
U.S. Senator Tammy Baldwin Pushes for Economic Growth in Wisconsin with Small Business Innovation ActSep 21st, 2016 by Tammy Baldwin
National reform will support Wisconsin, which ranks last nationally in startup activity and entrepreneurship growth
We Must Do More to Provide Debt Relief & Support to Students, Veterans Suffering from Wide-Ranging Impacts of ITT Tech ClosureSep 17th, 2016 by Tammy Baldwin
Senators now call on ED to “use its existing legal authority” to increase total debt relief and support available to former ITT Tech students
Baldwin, McCain, Schakowsky Introduce Reform Requiring Transparency in Prescription Drug Price IncreasesSep 15th, 2016 by Tammy Baldwin
The bipartisan and bicameral FAIR Drug Pricing Act takes the first step to address skyrocketing prescription drug costs